Clinical Trial: Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Sponsor and Collaborators
University of Medicine and Dentistry New Jersey

Principal Investigator
Andrew N. de la Torre, MD University of Medicine and Dentistry New Jersey


Continue Reading

ClinicalTrials.gov Identifier
NCT00949182